QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 immucell-updates-regulatory-status-of-product-development-initiative-for-re-tain

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develop...

 immucell-reports-preliminary-unaudited-sales-results-for-q1-2024-of-73m-up-111-yy

Total sales during the twelve-month period ended March 31, 2024 were 33% more than the twelve-month period ended March 31, 2023.

 earnings-scheduled-for-february-27-2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...

 immucell-q3-2023-gaap-eps-012-down-from-008-yoy-sales-540m-up-from-480m-yoy

ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.12) per share. This is a 50 percent decrease over losses of $(0.08) per...

 earnings-scheduled-for-november-13-2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr...

 immucell-announces-preliminary-unaudited-sales-results-for-q3-2023-sees-q3-revenue-54m-vs-48m-yoy

 ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures...

 immucell-q2-eps-018-down-from-009-yoy-sales-353m-down-from-386m-yoy

ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.18) per share. This is a 100 percent decrease over losses of $(0.09) pe...

 earnings-scheduled-for-august-10-2023

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share o...

 why-immucell-are-trading-higher-here-are-20-stocks-moving-premarket

Gainers Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) shares surged 131.6% to $4.03 in pre-market trading after gaining 15% on ...

 angiodynamics-disney-and-3-stocks-to-watch-heading-into-wednesday

With U.S. stock futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus toda...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION